all Flashcards

1
Q

childhood leukemia epidemiology- peak age, more common race and gender

A

age 1-4, W >B, boys more than girls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what race/ethnic group has inferior survival of ALL

A

black race and hispanic ethnicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

2 toxins that increase risk of ALL

A

mycotoxin and hydrocarbons (benzene)_

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

7 major genetic syndrome that I create risk of ALL

A

T21, NF1, bloom, falcon anemia (All less than AML), ataxia telangiectasia, Li fraumeni (aka TP53), and constitutional mismatch repair issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

4 genes for constitutional mismatch repait

A

MLH1 ,MSH2 .MSH6, PMS2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

increased risk for ALL with T21

A

20-30 fold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

common genetic change in T21 ALL but not alayws

A

`CRLF2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

leukemia concordance in monozygotic twins: if index is <1 year old, if index is 1-6, and if index is more than 6

A

<1: nearly 100% (KMT2a), 1-6: 10-20%, lower latency, and then more than 6 is very unlikely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

cytogenetic change associate with coagulopathy t diagnosis

A

17;19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

define M1 marrow2

A

<5% blasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

define M2 marrow

A

5-25% blasts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what type of marrow is leukemia by definition

A

M3 (more than 5% blasts0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

define CNS2

A

less than 5 CSF WBC and blasts are present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is CNS3

A

blasts present, ,more Etna 5 wb per microliter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Steinherz/Bleyer algorithm

A

is CNS3 if CSF WBC/CSF RBC > 2X peripheral blood WBC/ blood RBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

when to use steinherz algoritm

A

more than 10 RBC in CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

4 immunologic subtypes of B ALL

A

pro B, common B, pre B. mature B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what does pro B have on surface

A

CD79a, CD19, CD22 (at lesat 2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What cell surface marker often predicts KMT2a R

A

negative for Z D10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what does common B express on Cell

A

CD10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what doe Pre B press

A

cytoplasmic immunoglobulin heavy chain (mu)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

mature B has what

A

surface cell immunoglobulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Which leukemia expresses HLA-DR

A

almost al pre B ALL, most T cell are NOT, some AMLs are

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

is TDT positive in b ALL

A

usually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

MPO+ is what

A

MPAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

T cell ALL always expresses what and usually expresses what 2 other things

A

always cytoplasmic CD3 (cCD3+0, usually sCD3+ and TdT+, often also CD1a, 2 5 7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

age group for SR leukemia

A

1-9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

name 2 favorable genetic alterations in B ALL

A

hyperdiploid (N >50-53 and or favorable trisomies 4 and 10) AND ETV6 RUNX1 (t(12.21)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

what is the one neutral genetic alternation in b all

A

t (1;19) (q23, p13.3) the TCF3 (E2A) PBX1 and this is more common in Black people

30
Q

what is the pH+ chormosome

A

t(9;22) (q34; q11.2)

31
Q

what is KMT2a

A

t(11q23; Variable)

32
Q

what is the TCF3 rearrangement that is unfavorable

A

t(17;19)((q23, p13.3) TCF3 with HLF

33
Q

is iAMP21 favorable or not

34
Q

what comprises 3 drug induction ALL

A

VCR< steroids, asparaginase

35
Q

what is the 4 drug induction

A

VCR< steroids, asparaginase, daunorubicin

36
Q

2 categories of Ph like subtypes

A

ABL like (15%) vs CRLF2 lik (half of them, this is the one with focmmon aissues with JAK)

37
Q

what drug can you use for ABL ike fusion`

A

dasatanib or imatinib

38
Q

what drug can you use for CRLF2 rearrangemnts

39
Q

name a BiTE and how it works

A

Blina- connects CD3 to CD10

40
Q

name a drug antibody conjugation and how it works

A

ino- targets CD22 an then gets calicheadmicin into it

41
Q

what is ADE

A

cytarabine, daunt, etoposidew

42
Q

how to risk stratify T all

A

CNS3 gu really post remission MRD and end of consolidation MRD is more important

43
Q

what steroid is needed for T all

A

dexamethasone- slows relapse and improves OS

44
Q

how to treat MPAL

A

all therapy unless you have a key AML genetic targetm

45
Q

timing somnolence syndrome post CNS radiatino

46
Q

how to time MTX with CNS XRT

A

give MTX first

47
Q

imaging changes from cranial XRT

A

calcifications. you can get other issues

48
Q

what site is better for relapse of ALL

A

isolated extra medullary is bette than bone marrowh

49
Q

what is daratumumab

A

antibody to CD38

50
Q

time to HSSCT if relapse B ALL

A

if <36 months from initial diagnosis or isolated extramedulary <18 months

51
Q

what type of leukemia is more communion the following genetic syndromes: bloom NF, ataxia telangiectasia

A

bloom (AML >ALL), NF (AML >ALL), Ataxia telangiectasia (T/ALL or LLY)

52
Q

loeffler syndrome

A

hypereosinophilia (could be rare presenting cause of leukemia) with CHF, pulmonary infiltrates, cardiomegaly

53
Q

two types of AML with eosinophilia

A

either eosinophilic myeloid leukemia (M6 AML) or non-M6 with hypereosinophilia (characteristic rearrangement of chromosome 16)

54
Q

Features of mature B all (aka bursts)

A

t(2;8), t(8;14), t(8;22)– all are c-myc translations to heavy or light chain locus

55
Q

cd45 marks

A

hematopoietic

56
Q

name 4 immature (myeloid and lymphoid) markers

A

HLA DR, TDT lymphoid) CD117, CD34

57
Q

CD79a is

58
Q

cd99

59
Q

9 myeloid markers

A

CD13, 15, 33, 64/65, 11b (monocytic), 14 (monocytic), 163 (monocytic), MPO, NSE (monocytic)

60
Q

what antigen receptors gene rearrangements exist in T all

A

T ALL- almost all TCR, only 10% have Ig rearrangements

61
Q

CD10 lymphoblasts have what myeloid activity

62
Q

which is less mature- early B or Pre B

A

early is less mature- no cytoplasmic Ig or surface. Pre B is more mature, has cIg but not sIg

63
Q

how do you treat mature B cell ALL

A

like a advanced stage burkitts

64
Q

what’s the ETV6-RUNX1 fusion

A

t(12;21)(p13;q22)

65
Q

2 most common mutations in T ALL

A

activating NOTCH 1 and deletions in CDKN2A (9q21)

66
Q

define hypodiploid

67
Q

define hyperdiploid

A

N >50-53 and/or favorable trisomy (4 and 10) OR DNA index 1.16 or 53+ chromosomesw

68
Q

where do you radiate and at what dose for CNS with leukemia

A

whole brain and posterior halves of globes of eyes. pox dose is 1200 cGy, treatment for CNS3 is 1800 cY in 10 fractions for maintenance

69
Q

management testicular relapse ALL

A

chemo + 2400 cGy radiation

70
Q

time for stroke like symptoms after IT therapy

71
Q

timelime osteonecrosis with ALL

A

most within 2 years of diagnosis